Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

NCT00088010 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9369

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: Arzoxifene
DRUG: Placebo

Sponsor

Eli Lilly and Company